SAB Biotherapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SABS for the last quarter is 0.00 USD, and it's 100.00% lower compared to the previous quarter. The net income of Q3 24 is -10.35 M USD.